UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A single scale for comparing dose-intensity of all chemotherapy regimens in breast cancer: summation dose-intensity

Journal of clinical oncology, 1998-09, Vol.16 (9), p.3137-3147

1998

Volltextzugriff (PDF)

The relationship between high-dose treatment and combination chemotherapy: the concept of summation dose intensity

Clinical cancer research, 1998-09, Vol.4 (9), p.2027-2037

1998

Volltextzugriff (PDF)

Prognostic factors for prolonged progression-free survival with high-dose chemotherapy with autologous stem-cell support for advanced breast cancer

Journal of clinical oncology, 1995-08, Vol.13 (8), p.2043-2049

1995

Volltextzugriff (PDF)

Cyclophosphamide pharmacokinetics: correlation with cardiac toxicity and tumor response

Journal of clinical oncology, 1992-06, Vol.10 (6), p.995-1000

1992

Volltextzugriff (PDF)

Tumor Resistance to Alkylating Agents Conferred by Mechanisms Operative Only in Vivo

Science (American Association for the Advancement of Science), 1990-03, Vol.247 (4949), p.1457-1461

1990

Volltextzugriff (PDF)

High-dose multimodality therapy with autologous stem-cell support for stage IIIB breast carcinoma

Journal of clinical oncology, 1998-03, Vol.16 (3), p.1000-1007

1998

Volltextzugriff (PDF)

Phase II study of topotecan in metastatic non-small-cell lung cancer

Journal of clinical oncology, 1994-02, Vol.12 (2), p.347-352

1994

Volltextzugriff (PDF)

Double dose-intensive chemotherapy with autologous stem-cell support for metastatic breast cancer: no improvement in progression-free survival by the sequence of high-dose melphalan followed by cyclophosphamide, thiotepa, and carboplatin

Journal of clinical oncology, 1996-11, Vol.14 (11), p.2984-2992

1996

Volltextzugriff (PDF)

A phase I clinical and pharmacokinetic study of carboplatin and autologous bone marrow support

Journal of clinical oncology, 1989-05, Vol.7 (5), p.651-661

1989

Volltextzugriff (PDF)

Bone marrow autotransplantation for solid tumors--prospects

Journal of clinical oncology, 1989-04, Vol.7 (4), p.515-526

1989

Volltextzugriff (PDF)

Recombinant human tumor necrosis factor administered as a five-day continuous infusion in cancer patients: phase I toxicity and effects on lipid metabolism

Journal of clinical oncology, 1988-02, Vol.6 (2), p.344-350

1988

Volltextzugriff (PDF)

Non-small cell lung cancer : Novel treatment strategies

Chest, 1997-10, Vol.112 (4), p.266S-268S

FREI, E. III

1997

Volltextzugriff (PDF)

Use of peripheral-blood progenitor cells abrogates the myelotoxicity of repetitive outpatient high-dose carboplatin and cyclophosphamide chemotherapy

Journal of clinical oncology, 1993-08, Vol.11 (8), p.1583-1591

1993

Volltextzugriff (PDF)

High-dose ifosfamide with mesna uroprotection: a phase I study

Journal of clinical oncology, 1990-01, Vol.8 (1), p.170-178

1990

Volltextzugriff (PDF)

Acute in vivo resistance in high-dose therapy

Clinical cancer research, 1998-02, Vol.4 (2), p.483-491

1998

Volltextzugriff (PDF)

A phase I-II study of cyclophosphamide, thiotepa, and carboplatin with autologous bone marrow transplantation in solid tumor patients

Journal of clinical oncology, 1990-07, Vol.8 (7), p.1239-1245

1990

Volltextzugriff (PDF)

Improved prognosis of diffuse histiocytic and undifferentiated lymphoma by use of high dose methotrexate alternating with standard agents (M-BACOD)

Journal of clinical oncology, 1983-02, Vol.1 (2), p.91-98

1983

Volltextzugriff (PDF)

Weekly high-dose methotrexate and doxorubicin for osteosarcoma: the Dana-Farber Cancer Institute/the Children's Hospital--study III

Journal of clinical oncology, 1987-08, Vol.5 (8), p.1178-1184

1987

Volltextzugriff (PDF)

A Randomized Trial of Induction Chemotherapy plus High-Dose Radiation versus Radiation Alone in Stage III Non-Small-Cell Lung Cancer

The New England journal of medicine, 1990-10, Vol.323 (14), p.940-945

1990

Volltextzugriff (PDF)

Dose escalation of the hypoxic cell sensitizer etanidazole combined with ifosfamide, carboplatin, etoposide, and autologous hematopoietic stem cell support

Clinical cancer research, 1998-06, Vol.4 (6), p.1443-1449

1998

Volltextzugriff (PDF)

Alkylating Agent Resistance: In vitro Studies with Human Cell Lines

Proceedings of the National Academy of Sciences - PNAS, 1985-04, Vol.82 (7), p.2158-2162

1985

Volltextzugriff (PDF)

Selection bias in clinical trials

Journal of clinical oncology, 1985-08, Vol.3 (8), p.1142-1147

1985

Volltextzugriff (PDF)

The National Cancer Chemotherapy Program

Science (American Association for the Advancement of Science), 1982-08, Vol.217 (4560), p.600-606

Frei, Emil

1982

Volltextzugriff (PDF)

Therapeutic innovation: the up-front window

Clinical cancer research, 1998-11, Vol.4 (11), p.2573-2575

Frei, 3rd, E

1998

Volltextzugriff (PDF)

Osteogenic sarcoma: alterations in the pattern of pulmonary metastases with adjuvant chemotherapy

Journal of clinical oncology, 1983-04, Vol.1 (4), p.251-254

1983

Volltextzugriff (PDF)

1 – 25 von 362

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(286)
Mit Volltextzugriff
(232)

Publikationsform

Artikel
(360)
magazinearticle
(2)

Sprache

Englisch
(362)

Erscheinungsjahr

n.n

Thema

Humans
(311)
Science & Technology
(241)
Life Sciences & Biomedicine
(235)
Oncology
(154)
Female
(136)
Male
(127)
Adult
(120)
Middle Aged
(104)
Biological And Medical Sciences
(81)
Medical Sciences
(80)
Antineoplastic Agents
(76)
Pharmacology. Drug Treatments
(65)
Animals
(64)
Aged
(62)
Drug Therapy, Combination
(54)
Neoplasms - Drug Therapy
(51)
Antineoplastic Agents - Therapeutic Use
(50)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(50)
Child
(50)
Adolescent
(49)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

A single scale for comparing dose-intensity of all chemotherapy regimens in breast cancer: summation dose-intensity

The relationship between high-dose treatment and combination chemotherapy: the concept of summation dose intensity

Prognostic factors for prolonged progression-free survival with high-dose chemotherapy with autologous stem-cell support for advanced breast cancer

Cyclophosphamide pharmacokinetics: correlation with cardiac toxicity and tumor response

Tumor Resistance to Alkylating Agents Conferred by Mechanisms Operative Only in Vivo

High-dose multimodality therapy with autologous stem-cell support for stage IIIB breast carcinoma

Phase II study of topotecan in metastatic non-small-cell lung cancer

Double dose-intensive chemotherapy with autologous stem-cell support for metastatic breast cancer: no improvement in progression-free survival by the sequence of high-dose melphalan followed by cyclophosphamide, thiotepa, and carboplatin

A phase I clinical and pharmacokinetic study of carboplatin and autologous bone marrow support

Bone marrow autotransplantation for solid tumors--prospects

Recombinant human tumor necrosis factor administered as a five-day continuous infusion in cancer patients: phase I toxicity and effects on lipid metabolism

Non-small cell lung cancer : Novel treatment strategies

Use of peripheral-blood progenitor cells abrogates the myelotoxicity of repetitive outpatient high-dose carboplatin and cyclophosphamide chemotherapy

High-dose ifosfamide with mesna uroprotection: a phase I study

Acute in vivo resistance in high-dose therapy

A phase I-II study of cyclophosphamide, thiotepa, and carboplatin with autologous bone marrow transplantation in solid tumor patients

Improved prognosis of diffuse histiocytic and undifferentiated lymphoma by use of high dose methotrexate alternating with standard agents (M-BACOD)

Weekly high-dose methotrexate and doxorubicin for osteosarcoma: the Dana-Farber Cancer Institute/the Children's Hospital--study III

A Randomized Trial of Induction Chemotherapy plus High-Dose Radiation versus Radiation Alone in Stage III Non-Small-Cell Lung Cancer

Dose escalation of the hypoxic cell sensitizer etanidazole combined with ifosfamide, carboplatin, etoposide, and autologous hematopoietic stem cell support

Alkylating Agent Resistance: In vitro Studies with Human Cell Lines

Selection bias in clinical trials

The National Cancer Chemotherapy Program

Therapeutic innovation: the up-front window

Osteogenic sarcoma: alterations in the pattern of pulmonary metastases with adjuvant chemotherapy

Suchergebnisse filtern